Soy isoflavones improve sympathetic nervous system-driven non-alcoholic fatty liver disease through estrogen-like effects

SIFs ameliorate NAFLD by suppressing the cGAS–STING pathway via ER activation, countering SNS-induced hepatic inflammation and lipid accumulation.